Inovio Pharmaceuticals
INO
#9200
Rank
NZ$0.18 B
Marketcap
NZ$2.72
Share price
-3.11%
Change (1 day)
-23.53%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): NZ-$4.80

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$5.02. In 2024 the company made an earnings per share (EPS) of NZ-$6.89 an increase over its 2023 EPS that were of NZ-$10.62.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.80-30.27%
2024NZ-$6.89-35.14%
2023NZ-$10.62-56.62%
2022NZ-$24.49-19.54%
2021NZ-$30.4435.9%
2020NZ-$22.40-11.57%
2019NZ-$25.3315.24%
2018NZ-$21.98-2.78%
2017NZ-$22.606.93%
2016NZ-$21.14134.88%
2015NZ-$9.00-29.51%
2014NZ-$12.77-57.34%
2013NZ-$29.93146.55%
2012NZ-$12.1420.83%
2011NZ-$10.05-29.41%
2010NZ-$14.23-48.48%
2009NZ-$27.6310%
2008NZ-$25.1211.11%
2007NZ-$22.60-41.3%
2006NZ-$38.51-66.91%
2005NZ-$116.37110.61%
2004NZ-$55.26-61.63%
2003NZ-$144.00186.67%
2002NZ-$50.23
2001N/A-100%
2000NZ-$40.19-63.64%
1999NZ-$110.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$3.00-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.21-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ-$2.18-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.84-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$13.25-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.27-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
NZ$11.37-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA